型神经纤维瘤病相关听神经瘤治疗进展

Ⅱ型神经纤维瘤病(NF2)是常染色体显性遗传性疾病,病死率和病残率较高,双侧听神经瘤在其诊断与治疗中具有重要意义,平衡治疗方法与患者生活质量是NF2相关听神经瘤治疗的关键.本文综述NF2相关听神经瘤的治疗前监测、治疗方法和听力重建进展,以为临床诊断与治疗提供参考....

Full description

Saved in:
Bibliographic Details
Published in中国现代神经疾病杂志 Vol. 22; no. 12; pp. 1017 - 1020
Main Authors 杨智君, 刘丕楠
Format Journal Article
LanguageChinese
Published 100070 首都医科大学附属北京天坛医院神经外科 01.12.2022
Subjects
Online AccessGet full text
ISSN1672-6731
DOI10.3969/j.issn.1672-6731.2022.12.003

Cover

Abstract Ⅱ型神经纤维瘤病(NF2)是常染色体显性遗传性疾病,病死率和病残率较高,双侧听神经瘤在其诊断与治疗中具有重要意义,平衡治疗方法与患者生活质量是NF2相关听神经瘤治疗的关键.本文综述NF2相关听神经瘤的治疗前监测、治疗方法和听力重建进展,以为临床诊断与治疗提供参考.
AbstractList Ⅱ型神经纤维瘤病(NF2)是常染色体显性遗传性疾病,病死率和病残率较高,双侧听神经瘤在其诊断与治疗中具有重要意义,平衡治疗方法与患者生活质量是NF2相关听神经瘤治疗的关键.本文综述NF2相关听神经瘤的治疗前监测、治疗方法和听力重建进展,以为临床诊断与治疗提供参考.
Author 杨智君
刘丕楠
AuthorAffiliation 100070 首都医科大学附属北京天坛医院神经外科
AuthorAffiliation_xml – name: 100070 首都医科大学附属北京天坛医院神经外科
Author_FL YANG Zhi-jun
LIU Pi-nan
Author_FL_xml – sequence: 1
  fullname: YANG Zhi-jun
– sequence: 2
  fullname: LIU Pi-nan
Author_xml – sequence: 1
  fullname: 杨智君
– sequence: 2
  fullname: 刘丕楠
BookMark eNo9j7tKA0EYhaeIYIx5CxuLHf9_LruZUoI3CNhoHWZnZ8RFJuAgSvpUFtpoAoFUa2fjpRC38GnW8TFUDFYHzgfn46yRlh95S8gGAuUqVVslPQ3BU0wzlqQZR8qAMYqMAvAWaf_3q6QbQgkAiBxYCm3Cm8V1fFjE-ia-V7F-jbMqTidx_tZMXprbxyWaVZ_Pdbyffn3Mm6e7dbLi9Fmw3WV2yPHuzlF_Pxkc7h30twdJQBAiQZaDLID1jMXcKcOlFMZa5QruQGjZM64QKCRYnvZAoQVjdKaYtjmTxgreIZt_u5faO-1PhuXo4tz_GIdXRSjLfDz-vYkMQPBvRuheqw
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1672-6731.2022.12.003
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Recent advance on the treatment of neurofibromatosis type 2-associated vestibular schwannoma
EndPage 1020
ExternalDocumentID xdsjjbzz202212004
GrantInformation_xml – fundername: 国家自然科学基金
  funderid: (81974387)
GroupedDBID ---
-05
04C
2B.
4A8
5VS
92F
92I
93N
ABJNI
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
CCEZO
CCPQU
CIEJG
CW9
EBD
EIHBH
EOJEC
GROUPED_DOAJ
IPNFZ
KQ8
OBODZ
OK1
PQQKQ
PROAC
PSX
RIG
RNS
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1044-12b05d028ce1bf9c3554cee9fd3f04a58cfd41450e368091e0cca792aeb25ce43
ISSN 1672-6731
IngestDate Thu May 29 04:06:30 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords 神经纤维瘤病2型
神经瘤,听
综述
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1044-12b05d028ce1bf9c3554cee9fd3f04a58cfd41450e368091e0cca792aeb25ce43
PageCount 4
ParticipantIDs wanfang_journals_xdsjjbzz202212004
PublicationCentury 2000
PublicationDate 2022-12-01
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-01
  day: 01
PublicationDecade 2020
PublicationTitle 中国现代神经疾病杂志
PublicationTitle_FL Chinese Journal of Contemporary Neurology and Neurosurgery
PublicationYear 2022
Publisher 100070 首都医科大学附属北京天坛医院神经外科
Publisher_xml – name: 100070 首都医科大学附属北京天坛医院神经外科
SSID ssj0001130260
ssib017477097
ssib038074726
ssib051368963
ssib001103733
Score 2.3191574
SecondaryResourceType review_article
Snippet Ⅱ型神经纤维瘤病(NF2)是常染色体显性遗传性疾病,病死率和病残率较高,双侧听神经瘤在其诊断与治疗中具有重要意义,平衡治疗方法与患者生活质量是NF2相关听神经瘤治疗的关键.本文综述NF2相关听神经瘤的治疗前监测、治疗方法和听力重建进展,以为临床诊断与治疗提供参考.
SourceID wanfang
SourceType Aggregation Database
StartPage 1017
Title 型神经纤维瘤病相关听神经瘤治疗进展
URI https://d.wanfangdata.com.cn/periodical/xdsjjbzz202212004
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RAdKgtFC_iJ36WIp2T7DqZmWRmjsluliJYRFrorSTZROlhBXcF2ZuHnjzoRVso9LTevPhxEPfgr1njz_C92dlN0FWql_DyZt43yXuZzEsI2Qhk4RVZljcCJZOGhAzXSNOsaHCTKuElLAHtcbfFVrC5I-_t-rtLZ17Uu0sGaTMbLuwr-Z-oAg7iil2y_xDZOVNAAAzxhSNEGI6nijGNfWpiqiMaKxpaGIAoorpjgZCG0mEiCxjtMEZR7VsAhjTygdNIWIaMhq3FDB15QCOOSMQEyCrWNOogKyCPPDr9n-Ws5KWxRBFh2zIHcW0k1DGNmB2KaCj-IA4ExTVtQVabam6lgLh5BnUjobaAQbundpiomgIWajRgqo2x7EBkyOrrHpz_socE30sodofGhoYBKgSAFtYGYNhyXghBRQ8x4B2AEWjjfJgM6mg580vsqNBl0oanNaMyVuW2c6LjbMlDvsg7lgr1cdJrySVQHFstvHr24bx-lfFaLsGbZa0ugUqQLcp5wgTG5jyU0ZzLaKLP7Eo3E1Wun-_AfN7t7--nwyHO8rj9ou4KVwp3OqxE8daDh1VNjZ2k1TMBPMEqxapXz_jDAqmqGt73RKCN-6abXejEV-PTbv2Zbqtkwyl-929q2z66XpH0HtVKvu3z5Jx7VlsPpxfeBbI0fHyRrN53u1EuETE5eVm-OynHr8qvo3L8uTwalYcH5fGXycGnyev3buho9P3juHx7-OPb8eTDm8tkpxNvtzYb7ickjb7HJH7TE2zqQhWe5V5amAzrcygsTdEVBZOJr7OiKz3psxzshuI7Z3BPVIYnecr9LJfiClnuPenlV8m6TGSq0Dee8GXKukaLIGCJL3LFdJqra-S2s3fP3WT6e7_F6fppJt0gZ6tL5iZZHjx9lt-C4nmQrrnwrtnFp58bmo-u
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%9E%8B%E7%A5%9E%E7%BB%8F%E7%BA%A4%E7%BB%B4%E7%98%A4%E7%97%85%E7%9B%B8%E5%85%B3%E5%90%AC%E7%A5%9E%E7%BB%8F%E7%98%A4%E6%B2%BB%E7%96%97%E8%BF%9B%E5%B1%95&rft.jtitle=%E4%B8%AD%E5%9B%BD%E7%8E%B0%E4%BB%A3%E7%A5%9E%E7%BB%8F%E7%96%BE%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E6%9D%A8%E6%99%BA%E5%90%9B&rft.au=%E5%88%98%E4%B8%95%E6%A5%A0&rft.date=2022-12-01&rft.pub=100070+%E9%A6%96%E9%83%BD%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E5%8C%97%E4%BA%AC%E5%A4%A9%E5%9D%9B%E5%8C%BB%E9%99%A2%E7%A5%9E%E7%BB%8F%E5%A4%96%E7%A7%91&rft.issn=1672-6731&rft.volume=22&rft.issue=12&rft.spage=1017&rft.epage=1020&rft_id=info:doi/10.3969%2Fj.issn.1672-6731.2022.12.003&rft.externalDocID=xdsjjbzz202212004
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fxdsjjbzz%2Fxdsjjbzz.jpg